MHRA Drug Safety Update – November 2018

MHRA Drug Safety Update – November 2018

November 14, 2018

Date issued: 14th November 2018

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue 4, November 2018) has been published and includes articles on:

  • Hydrochlorthiazide: risk of non-melanoma skin cancer, particularly in long-term use.
  • Systemic and inhaled fluoroquinolones: small increased risk of aortic aneurysm and dissection; advice for prescribing in high risk patients.
  • Support Yellow Card: help improve the safety of medicines in pregnancy and breastfeeding, and in babies and children.

To see the latest MHRA Drug Safety Update in full, visit the website.


Posted in:

More Latest News >